follow sterile compounding guidelines Injection site: Abdomen subcutaneous, rotating sites each injection Stacking: Often evaluated in combination with CJC-1295/Ipamorelin for complementary anabolic-lipolytic effects, or with BPC-157 for tissue repair support These parameters reflect research protocols and published clinical trial data
Detailed Product Description 5-Amino-1-Methylquinolinium (5-Amino-1MQ) is a first-in-class, selective NNMT inhibitor designed for research into metabolic regulation, obesity, diabetes, nonalcoholic fatty liver disease, and age-associated muscle degeneration
Avoid freeze/thaw cycles, which can degrade peptide structure
If you're isolating adipocyte lipolysis without confounding glucose or growth signaling, AOD-9604 provides receptor-level specificity that full hGH and most other lipolytic agents don't
Many practitioners combine these protocols for comprehensive body composition optimization